全文获取类型
收费全文 | 197146篇 |
免费 | 35493篇 |
国内免费 | 2557篇 |
专业分类
耳鼻咽喉 | 5658篇 |
儿科学 | 6597篇 |
妇产科学 | 3287篇 |
基础医学 | 9485篇 |
口腔科学 | 2760篇 |
临床医学 | 31106篇 |
内科学 | 56804篇 |
皮肤病学 | 8103篇 |
神经病学 | 19523篇 |
特种医学 | 8789篇 |
外国民族医学 | 8篇 |
外科学 | 47811篇 |
综合类 | 821篇 |
现状与发展 | 72篇 |
一般理论 | 40篇 |
预防医学 | 10887篇 |
眼科学 | 4484篇 |
药学 | 3882篇 |
中国医学 | 78篇 |
肿瘤学 | 15001篇 |
出版年
2024年 | 526篇 |
2023年 | 4947篇 |
2022年 | 1293篇 |
2021年 | 3867篇 |
2020年 | 6595篇 |
2019年 | 2947篇 |
2018年 | 8265篇 |
2017年 | 8031篇 |
2016年 | 9244篇 |
2015年 | 9393篇 |
2014年 | 16819篇 |
2013年 | 17515篇 |
2012年 | 8534篇 |
2011年 | 8699篇 |
2010年 | 12126篇 |
2009年 | 15802篇 |
2008年 | 8789篇 |
2007年 | 7141篇 |
2006年 | 9552篇 |
2005年 | 6770篇 |
2004年 | 5868篇 |
2003年 | 4755篇 |
2002年 | 4725篇 |
2001年 | 4451篇 |
2000年 | 3620篇 |
1999年 | 3882篇 |
1998年 | 4218篇 |
1997年 | 3891篇 |
1996年 | 3755篇 |
1995年 | 3583篇 |
1994年 | 2249篇 |
1993年 | 1845篇 |
1992年 | 1744篇 |
1991年 | 1759篇 |
1990年 | 1390篇 |
1989年 | 1527篇 |
1988年 | 1320篇 |
1987年 | 1157篇 |
1986年 | 1172篇 |
1985年 | 1023篇 |
1984年 | 851篇 |
1983年 | 818篇 |
1982年 | 825篇 |
1981年 | 690篇 |
1980年 | 613篇 |
1979年 | 538篇 |
1978年 | 562篇 |
1977年 | 590篇 |
1975年 | 448篇 |
1972年 | 437篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
Breast Elastography: How to Perform and Integrate Into a “Best-Practice” Patient Treatment Algorithm
Breast elastography has been available for more than 15 years but is not widely incorporated into clinical practice. Many publications report extremely high accuracy for various breast elastographic techniques. However, results in the literature are extremely variable. This variability is most likely due to variations in technique, a relatively steep learning curve, and variability in methods between vendors. This article describes our protocol for performing breast elastography using both strain elastography and shear wave elastography, which produces high sensitivity and specificity. Additionally, we will describe the most commonly known false-positive and false-negative lesions as well as how to detect them. 相似文献
73.
J. Savige L. Amos Frank Ierino H. G. Mack R. C. Andrew Symons P. Hughes 《Ophthalmic genetics》2016,37(4):369-376
Background: Dense deposit disease and atypical hemolytic uremic syndrome are often caused by Complement Factor H (CFH) mutations. This study describes the retinal abnormalities in dense deposit disease and, for the first time, atypical haemolytic uremic syndrome. It also reviews our understanding of drusen pathogenesis and their relevance for glomerular disease. Methods: Six individuals with dense deposit disease and one with atypical haemolytic uremic syndrome were studied from 2 to 40 years after presentation. Five had renal transplants. All four who had genetic testing had CFH mutations. Individuals underwent ophthalmological review and retinal photography, and in some cases, optical coherence tomography, and further tests of retinal function. Results: All subjects with dense deposit disease had impaired night vision and retinal drusen or whitish-yellow deposits. Retinal atrophy, pigmentation, and hemorrhage were common. In late disease, peripheral vision was restricted, central vision was distorted, and there were scotoma from sub-retinal choroidal neovascular membranes and atypical serous retinopathy. Drusen were present but less prominent in the young person with atypical uremic syndrome due to a heterozygous CFH mutation. Conclusions: Drusen are common in forms of C3 glomerulopathy caused by compound heterozygous or heterozygous CFH mutations. They are useful diagnostically but also impair vision. Drusen have an identical composition to glomerular deposits. They are also identical to the drusen of age-related macular degeneration, and may respond to the same treatments. Individuals with a C3 glomerulopathy should be assessed ophthalmologically at diagnosis, and monitored regularly for vision-threatening complications. 相似文献
74.
The term “oligometastatic prostate cancer” refers to a heterogeneous group of disease states currently defined solely on the basis of clinical features. Oligorecurrent disease, de novo oligometastases, and oligoprogressive disease likely have unique biologic underpinnings and natural histories. Evidence suggesting the existence of a subset of patients who harbor prostate cancer with limited metastatic potential currently includes disparate and overwhelmingly retrospective reports. Nevertheless, emerging prospective data have corroborated the “better-than-expected,” retrospectively observed outcomes, particularly in the setting of oligorecurrent prostate cancer. Improved functional imaging with prostate-specific membrane antigen-targeted strategies may enhance the identification of patients with oligometastatic prostate cancer in the short term. In the long term, refinement of the oligometastatic case definition likely will require biologic risk-stratification schemes. To determine optimal treatment strategies and identify patients most likely to benefit from metastasis-directed therapy, future efforts should focus on conducting high-quality, prospective trials with much-needed molecular correlative studies. 相似文献
75.
76.
77.
78.
79.
Erik de Bakker Mirthe A. M. van der Putten Martijn W. Heymans Sander W. Spiekstra Taco Waaijman Liselotte Butzelaar Vera L. Negenborn Vivian K. Beekman Erman O. Akpinar Thomas Rustemeyer Frank B. Niessen Susan Gibbs 《Experimental dermatology》2021,30(1):169-178
Unpredictable hypertrophic scarring (HS) occurs after approximately 35% of all surgical procedures and causes significant physical and psychological complaints. Parallel to the need to understanding the mechanisms underlying HS formation, a prognostic tool is needed. The objective was to determine whether (systemic) immunological differences exist between patients who develop HS and those who develop normotrophic scars (NS) and to assess whether those differences can be used to identify patients prone to developing HS. A prospective cohort study with NS and HS groups in which (a) cytokine release by peripheral blood mononuclear cells (PBMC) and (b) the irritation threshold (IT) after an irritant (sodium lauryl sulphate) patch test was evaluated. Univariate regression analysis of PBMC cytokine secretion showed that low MCP‐1, IL‐8, IL‐18 and IL‐23 levels have a strong correlation with HS (P < .010‐0.004; AUC = 0.790‐0.883). Notably, combinations of two or three cytokines (TNF‐a, MCP‐1 and IL‐23; AUC: 0.942, Nagelkerke R2: 0.727) showed an improved AUC indicating a better correlation with HS than single cytokine analysis. These combination models produce good prognostic results over a broad probability range (sensitivity: 93.8%, specificity 86.7%, accuracy 90,25% between probability 0.3 and 0.7). Furthermore, the HS group had a lower IT than the NS group and an accuracy of 68%. In conclusion, very fundamental immunological differences exist between individuals who develop HS and those who do not, whereas the cytokine assay forms the basis of a predictive prognostic test for HS formation, the less invasive, easily performed irritant skin patch test is more accessible for daily practice. 相似文献
80.
Marie V. Plaisime PhD MPH Marie Jipguep-Akhtar PhD Joseph J. Locascio PhD Harolyn M. E. Belcher MD MHS Rachel R. Hardeman PhD MPH Katherine Picho-Kiroga PhD Sylvia P. Perry PhD Sean M. Phelan PhD MPH Michelle van Ryn PhD LMFT MPH John F. Dovidio PhD 《Health services research》2023,58(Z2):229-237